Need access to NeoLink? Contact your Sales rep or our Client Services team at 866.776.5907, Option 3

May 7, 2025

 

To serve our customers and their patients, we evaluate our test menu regularly to align with clinical guidelines. Effective May 12th, we will improve our test offerings to serve your diagnostic needs. While specific tests will be discontinued, we have thoroughly evaluated and identified more appropriate tests from our menu that align with recommended guidelines. Below is a comprehensive list of affected tests and their recommended replacements.

Orders for the NeoTYPE^® Discovery Profile and replaced tests will not be automatically converted. Please order the new test using the appropriate requisition form or the online ordering portal to avoid testing delays.

 

Retired Test	Methodology	Replacement Option	Methodology
NeoTYPE® Discovery Profile for Solid Tumors	DNA NGS, FISH, IHC	Neo Comprehensive® - Solid Tumor	DNA & RNA NGS
Brain NGS Fusion Panel	RNA Fusion	NeoTYPE® DNA & RNA Brain & MGMT Promoter Methylation Analysis	DNA & RNA NGS, FISH & PCR
Ewing Sarcoma NGS Fusion Panel	RNA Fusion	Sarcoma Comprehensive NGS Fusion Panel	RNA Fusion
NeoTYPE® Liposarcoma Fusion Panel
Non-Ewing Sarcoma NGS Fusion Panel
Rhabdomosarcoma NGS Fusion Panel
Brain NGS Fusion Panel	RNA Fusion	Universal Solid Tumor NGS Fusion Panel or Neo Comprehensive® - Solid Tumor	RNA Fusion DNA & RNA NGS
Cholangio/Pancreatic Carcinoma NGS Fusion Panel
Colorectal NGS Fusion Panel
Lung NGS Fusion Panel
Lung Limited NGS Fusion Panel
Prostate Gland NGS Fusion Panel
Salivary Gland NGS Fusion Panel
Thyroid NGS Fusion Panel

 

At NeoGenomics, we are committed to consistently improving our customer communication. Will you answer a few short questions so we can ensure you get the newsletter content you need when you need it?

I like to receive information from NeoGenomics:
☐ Weekly
☐ Bi-weekly
☐ Monthly
☐ Quarterly

Complete the survey!